Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses
Delia Goletti, Linda Petrone, Davide Manissero, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 12, pp. 1784-1789
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Correlates of protection against SARS‐CoV‐2 infection and COVID‐19 disease
David Goldblatt, Galit Alter, Shane Crotty, et al.
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 6-26
Open Access | Times Cited: 233
Scientific rationale for developing potent RBD-based vaccines targeting COVID-19
Harry Kleanthous, Judith M. Silverman, Karen W. Makar, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 136
T Cell Responses to SARS-CoV-2
Alessandro Sette, John Sidney, Shane Crotty
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 343-373
Closed Access | Times Cited: 114
ImmunosuppressiveTherapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis Patients
Andrea Picchianti Diamanti, Alessandra Aiello, Bruno Laganà, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 80
Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis
Chiara Farroni, Andrea Picchianti Diamanti, Alessandra Aiello, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 45
The Importance of Measuring SARS-CoV-2-Specific T-Cell Responses in an Ongoing Pandemic
Linda Petrone, Alessandro Sette, Rory D. de Vries, et al.
Pathogens (2023) Vol. 12, Iss. 7, pp. 862-862
Open Access | Times Cited: 25
The immunogenicity and reactogenicity of four COVID-19 booster vaccinations against SARS-CoV-2 variants following CoronaVac or ChAdOx1 nCoV-19 primary series
Nasikarn Angkasekwinai, Suvimol Niyomnaitham, Jaturong Sewatanon, et al.
Asian Pacific Journal of Allergy and Immunology (2023)
Open Access | Times Cited: 23
B-cell-depleted patients with persistent SARS-CoV-2 infection: combination therapy or monotherapy? A real-world experience
Alessandra D’Abramo, Serena Vita, Alessia Beccacece, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 10
Performance of the T-SPOTⓇ.COVID test for detecting SARS-CoV-2-responsive T cells
Margaret Kruse, C.H. Dark, Megan Aspden, et al.
International Journal of Infectious Diseases (2021) Vol. 113, pp. 155-161
Open Access | Times Cited: 42
A Pilot Study for the Evaluation of an Interferon Gamma Release Assay (IGRA) To Measure T-Cell Immune Responses after SARS-CoV-2 Infection or Vaccination in a Unique Cloistered Cohort
Pablo Barreiro, Juan Carlos Sanz, Jesús San Román, et al.
Journal of Clinical Microbiology (2022) Vol. 60, Iss. 3
Open Access | Times Cited: 35
Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review
Areez Shafqat, Shameel Shafqat, Sulaiman Al Salameh, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33
Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review
Jingjing Lv, Hui Wu, Junjie Xu, et al.
Infectious Diseases of Poverty (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 33
Humoral and cellular responses to spike of δ SARS-CoV-2 variant in vaccinated patients with immune-mediated inflammatory diseases
Linda Petrone, Andrea Picchianti Diamanti, Gian Domenico Sebastiani, et al.
International Journal of Infectious Diseases (2022) Vol. 121, pp. 24-30
Open Access | Times Cited: 29
Accuracy of QuantiFERON SARS-CoV-2 research use only assay and characterization of the CD4+ and CD8+ T cell-SARS-CoV-2 response: comparison with a homemade interferon-γ release assay
Alessandra Aiello, Andrea Coppola, Valentina Vanini, et al.
International Journal of Infectious Diseases (2022) Vol. 122, pp. 841-849
Open Access | Times Cited: 29
Humoral and Cellular Response to Spike of Delta SARS-CoV-2 Variant in Vaccinated Patients With Multiple Sclerosis
Linda Petrone, Carla Tortorella, Alessandra Aiello, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 24
Prevalence and functional profile of SARS-CoV-2 T cells in asymptomatic Kenyan adults
Taraz Samandari, Joshua Ongalo, Kimberly D. McCarthy, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 13
Open Access | Times Cited: 13
Combined antiviral therapy as effective and feasible option in allogenic hematopoietic stem cell transplantation during SARS-COV-2 infection: a case report
Serena Vita, Alessandra D’Abramo, Andrea Coppola, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Dynamic Evolution of Humoral and T-Cell Specific Immune Response to COVID-19 mRNA Vaccine in Patients with Multiple Sclerosis Followed until the Booster Dose
Serena Ruggieri, Alessandra Aiello, Carla Tortorella, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8525-8525
Open Access | Times Cited: 10
Screening HLA-A-restricted T cell epitopes of SARS-CoV-2 and the induction of CD8+ T cell responses in HLA-A transgenic mice
Xiaoxiao Jin, Yan Ding, Shihui Sun, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 12, pp. 2588-2608
Open Access | Times Cited: 23
Humoral and Cellular Immunogenicity of Six Different Vaccines against SARS-CoV-2 in Adults: A Comparative Study in Tunisia (North Africa)
Mélika Ben Ahmed, Hèdia Bellali, Mariem Gdoura, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1189-1189
Open Access | Times Cited: 17
Coordinated innate and T-cell immune responses in mild COVID-19 patients from household contacts of COVID-19 cases during the first pandemic wave
Alessandra Aiello, Adriano Grossi, Silvia Meschi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Humoral and cellular immune response over 9 months of mRNA-1273, BNT162b2 and ChAdOx1 vaccination in a University Hospital in Spain
Leire Fernández-Ciriza, Álvaro González, José Luís del Pozo, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 14
Factors influencing the SARS-CoV-2 infection and vaccination induced immune response in rheumatoid arthritis
Dóra Németh, Hajnalka Vágó, László Tóthfalusi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
Natural and hybrid immunity after SARS-CoV-2 infection in children and adolescents
Tobias Rothoeft, Claudia S. Maier, A Talarico, et al.
Infection (2024) Vol. 52, Iss. 4, pp. 1449-1458
Open Access | Times Cited: 2
Cell immunity to SARS-CoV-2 after natural infection and/or different vaccination regimens
Esther Culebras, Mercedes Martínez, Consuelo Novella, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top